News And Events

Type 1 diabetes (T1D) is a complex autoimmune disease characterized by the immune system’s destruction of insulin-producing β-cells in the pancreas. Read More

Beta-cell destruction is a defining feature of type 1 diabetes (T1D), where the body’s own immune system selectively targets and destroys insulin-producing cells in the pancreas. Read More

In preclinical studies of type 1 diabetes (T1D), accurate measurement of blood glucose levels and assessment of beta-cell mass are critical for understanding disease progression and therapeutic efficacy. Read More

Balancing the protection of insulin-producing beta cells with effective immune control remains the central therapeutic challenge in autoimmune diabetes. Read More

Selecting the appropriate type 1 diabetes (T1D) model is crucial for generating meaningful and translatable research outcomes. Read More

CIA Model: The Key to Unveiling the Mechanisms of Multisystem Damage in Rheumatoid ArthritisRheumatoid arthritis (RA) is not merely a disorder confined to the joints; it is a complex, chronic inflammatory condition with far - reaching consequences. Read More

CIA Model: Innovative Applications of Collagen II InducedIn the dynamic field of life science research, the construction of disease models stands as a pivotal cornerstone. Read More

CIA Model: A Key Tool for Analyzing Autoimmune ResponseAutoimmune diseases, characterized by the immune system's abnormal attack on the body's own tissues, have become a global health challenge. Read More

CIA Model: The Core Tool for Gaining Insights into Synovial InflammationSynovial inflammation, a common pathological process in autoimmune arthritis and other joint - related diseases, poses a significant threat to human health. Read More